Champions Oncology Company
Champions Oncology develops advanced technology solutions and services for personalizing the development and use of oncology drugs.
Total Funding:
36800000.0
Headquarters:
Hackensack, New Jersey, United States
Funding Status:
IPO
Employee Number:
51-100
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
Post-IPO Equity
Technology:
Cancer
Investor Type:
Company
Last Funding Date:
2015-03-12
Investors Number:
4.0
Founded Date:
1985-01-01
Industry:
End-to-End Drug Development